We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+1%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$65.2B
AUM Growth
+$6.51B
(+11%)
Cap. Flow
+$6.71B
Cap. Flow
% of AUM
10.29%
Top 10 Holdings %
Top 10 Hldgs %
15.4%
Holding
2,716
New
313
Increased
1,389
Reduced
876
Closed
123
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$213M |
| 2 |
Cigna
CI
|
+$207M |
| 3 |
Comcast
CMCSA
|
+$164M |
| 4 |
Zoom
ZM
|
+$155M |
| 5 |
Johnson & Johnson
JNJ
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$237M |
| 2 |
TSMC
TSM
|
+$214M |
| 3 |
NVIDIA
NVDA
|
+$138M |
| 4 |
Adobe
ADBE
|
+$133M |
| 5 |
Pultegroup
PHM
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.59% |
| 2 | Financials | 13.87% |
| 3 | Industrials | 12.52% |
| 4 | Consumer Discretionary | 12.44% |
| 5 | Healthcare | 12.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1376
PetMed Express
PETS
$42.3M
| $2.4M | ﹤0.01% |
591,435
-91,596
| -13% | -$391K |
|
1377
Arcutis Biotherapeutics
ARQT
$3.3B
| $2.39M | ﹤0.01% |
257,357
+226,258
| +728% | +$2.05M |
|
1378
Scholastic
SCHL
$780M
| $2.39M | ﹤0.01% |
67,417
+25,958
| +63% | +$928K |
|
1379
Stride
LRN
$3.29B
| $2.38M | ﹤0.01% |
33,805
-6,506
| -16% | -$434K |
|
1380
State Street Energy Select Sector SPDR ETF
XLE
$39.8B
| $2.38M | ﹤0.01% |
52,164
+22,132
| +74% | +$1.03M |
|
1381
Crescent Energy
CRGY
$4.1B
| $2.37M | ﹤0.01% |
+200,293
| New | +$2.36M |
|
1382
DHT Holdings
DHT
$2.93B
| $2.37M | ﹤0.01% |
204,988
+52,803
| +35% | +$620K |
|
1383
Independent Bank
INDB
$4.02B
| $2.36M | ﹤0.01% |
46,615
+25,749
| +123% | +$1.29M |
|
1384
HSBC
HSBC
$355B
| $2.35M | ﹤0.01% |
54,116
+13,698
| +34% | +$589K |
|
1385
Vita Coco
COCO
$3.73B
| $2.35M | ﹤0.01% |
84,475
+4,234
| +5% | +$112K |
|
1386
Kiniksa Pharmaceuticals
KNSA
$6.07B
| $2.35M | ﹤0.01% |
125,995
-33,328
| -21% | -$624K |
|
1387
StoneCo
STNE
$2.42B
| $2.35M | ﹤0.01% |
198,895
-2,941
| -1% | -$43.4K |
|
1388
Equity Lifestyle Properties
ELS
$12.4B
| $2.35M | ﹤0.01% |
36,177
+10,818
| +43% | +$678K |
|
1389
Nextpower Inc
NXT
$15.9B
| $2.35M | ﹤0.01% |
50,090
+8,547
| +21% | +$425K |
|
1390
Liberty Latin America Class C
LILAK
$1.66B
| $2.35M | ﹤0.01% |
268,167
+117,393
| +78% | +$875K |
|
|
CFB
1391
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $2.34M | ﹤0.01% |
166,833
+46,711
| +39% | +$604K |
|
1392
Power Integrations
POWI
$3.54B
| $2.33M | ﹤0.01% |
33,253
+1,942
| +6% | +$139K |
|
1393
Patrick Industries
PATK
$2.81B
| $2.33M | ﹤0.01% |
32,249
-4,000
| -11% | -$293K |
|
1394
Methode Electronics
MEI
$595M
| $2.33M | ﹤0.01% |
225,177
+124,677
| +124% | +$1.43M |
|
1395
Movado Group
MOV
$822M
| $2.33M | ﹤0.01% |
93,643
+1,255
| +1% | +$32.8K |
|
1396
Sinclair Inc
SBGI
$989M
| $2.33M | ﹤0.01% |
181,090
-23,270
| -11% | -$298K |
|
1397
iShares MSCI USA Min Vol Factor ETF
USMV
$24.4B
| $2.31M | ﹤0.01% |
27,458
+13,818
| +101% | +$1.14M |
|
1398
Invitation Homes
INVH
$17.7B
| $2.3M | ﹤0.01% |
65,377
+25,104
| +62% | +$873K |
|
|
AAMI
1399
Acadian Asset Management
AAMI
$3.25B
| $2.3M | ﹤0.01% |
103,690
+23,232
| +29% | +$524K |
|
1400
WD-40
WDFC
$3.13B
| $2.29M | ﹤0.01% |
10,420
+4,513
| +76% | +$1.04M |
|
Similar funds
VGA
AQR Capital Management's Q2 2024 Portfolio in Review
As of Q2 2024, AQR Capital Management held 2,716 positions worth $65.2B, up 11% from $58.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
AQR Capital Management deployed $6.71B of net new capital in Q2 2024, opening 313 new positions and adding to 1,389 existing holdings. Its largest new stake was Solventum: 1,217,998 shares worth $62.6M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Humana, an estimated $237M trimmed.
- AQR Capital Management's largest Q2 2024 buy was Solventum: 1,217,998 shares worth $62.6M.
- AQR Capital Management added most to ExxonMobil in Q2 2024, an estimated $213M increase.
- AQR Capital Management's biggest Q2 2024 reduction was Humana, cutting an estimated $237M.
- AQR Capital Management fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $27.7M.
- AQR Capital Management's ten largest holdings make up 15% of its $65.2B portfolio in Q2 2024.
- AQR Capital Management opened 313 new positions and closed 123 in Q2 2024.
- AQR Capital Management's portfolio value rose 11% quarter-over-quarter to $65.2B.
Based on AQR Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.